Why ER Medical?

Why serious manufacturers choose a more coordinated route into Turkiye

In Turkiye, stronger market entry starts with a structure that aligns access, trust, and regulation from the outset.

Request Partnership View Partners

Direct clinical access

Established relationships with private clinics and specialist physicians support trust from day one.

24,000-30,000 pharmacy reach

A route into the national ordering infrastructure used by pharmacies across Turkiye.

Active regulatory execution

TITCK-related processes are coordinated end-to-end on your behalf.

Why the model works

Turkiye rewards prepared brands, not just good products

The opportunity is substantial, but market entry depends on access, local credibility, and execution discipline arriving together.

Turkiye is one of Europe's fastest-growing markets in pharmaceuticals and medical products. Entering it, however, means knowing which doors matter, knowing the people behind them, and navigating a dense regulatory maze without losing time.

ER Medical is built for that exact intersection. We connect market access, clinical trust, and regulatory execution so manufacturers enter Turkiye with structure rather than guesswork.

What sets us apart

One coordinated model across the three pressures that decide market entry

The real advantage is not one capability on its own, but a structure that keeps the most important parts of market entry moving together with more control and less friction.

Direct clinic and physician network

Relationship capital that supports early clinical credibility.

National pharmacy access

Infrastructure that supports national visibility and availability.

Active regulatory management

Compliance leadership that keeps complex processes moving.

Integrated partner model

One operating model that keeps every workstream aligned.

Direct access to critical channels

The relationships that actually move products in Turkiye

Channel access is not an abstract promise. It determines who sees the product, who trusts it, and how quickly it becomes commercially real.

Established access to private clinics and specialist physicians

The right product still needs the right voice and the right clinical setting.

Private clinics & specialists

Private clinics

Established relationships

Specialist-led

Clinical trust context

Day-one

Warm market entry

We maintain long-standing working relationships with leading private clinics across Turkiye. That gives your product a credible introduction to the physicians who shape early trust, recommendation, and usage.

In foreign markets, brands often succeed not because of the product alone, but because the right people choose to stand behind it. We already have a seat at that table.

One route into nationwide pharmacy visibility

Scale in Turkiye depends on more than local warehousing. It depends on being orderable inside the systems pharmacies actually use.

24,000-30,000 pharmacies

24k-30k

Pharmacy reach

National

Ordering visibility

Faster

Route to listing

We have direct access to the national online infrastructure through which pharmacies source products. That creates a path for your product to be listed, ordered, and made physically available across the country.

Many foreign brands spend years trying to build that reach. We shorten that path.

Speed and reliability in regulation

Execution across the TITCK process, not just guidance around it

For foreign manufacturers, the Turkish Medicines and Medical Devices Agency can be demanding and time-intensive. Delays usually come from fragmented ownership and poor sequencing.

What changes with us

We work inside the process on your behalf

The regulatory team is not there to comment from the side. We manage the route end-to-end, minimise avoidable delay, and protect manufacturers from unnecessary cost.

End-to-end

Process ownership

Core workstreams

Lower delay

Better sequencing

Licensing and registration

Submission planning and documentation flow are structured to keep progress moving.

GMP alignment

Technical and compliance workstreams are prepared around local expectations and timing.

Import permissions

Import approvals and operational dependencies are coordinated before they become bottlenecks.

Reimbursement pathways

Commercial implications are considered early where reimbursement or institutional access matters.

Why not just another distributor?

Because products do better when trust, access, and regulation are managed together

It is not difficult to find a distributor in Turkiye. It is far harder to find one partner that can coordinate the clinical, pharmacy, and regulatory layers at the same time.

Clinical credibility

A physician and clinic network helps the product arrive in a trusted context, not as a cold listing.

Pharmacy access

National ordering visibility turns market entry into something commercially reachable rather than theoretical.

Regulatory completeness

A complete compliance foundation reduces delay, protects budget, and supports a cleaner launch.

Where to start

If you want your product to land in Turkiye with the right network behind it, start here

The Turkish market is waiting. If you want your product backed by physicians, thousands of pharmacies, and a complete regulatory base from day one, this is the right first conversation.

Start the Conversation

What brands gain

Why this structure changes the outcome

The benefit is not only faster access. It is a stronger, more credible market entry with fewer avoidable mistakes.

Faster movement from first assessment to real in-market activation

A stronger first impression with physicians, clinics, and pharmacy stakeholders

Lower coordination burden for overseas teams entering Turkiye

A partner model built around long-term market presence, not short-term resale

Partnership enquiry

Looking to enter the Turkish market with your medical or supplement products?

Start a partnership discussion with a team focused on regulatory readiness, medical credibility, and serious route-to-market execution.

Become a Partner Contact Us